Predictive Value of Systemic Immune Inflammation Index in Septic Patients with Acute Kidney Injury.

BACKGROUND: Acute kidney injury (AKI) is common in patients with sepsis and may result in death. Systemic immune inflammation index (SII) is associated with kidney injury, but its predictive value for AKI in patients with sepsis remains unclear. OBJECTIVE: This study aimed to explore the predictive value of SII in sepsis patients with AKI. METHODS: From January 2020 to December 2022, 221 patients with sepsis treated in our hospital were retrospectively collected. The patients were divided into AKI group (n = 61) and control group (n = 160). Clinical characteristics and SII level were compared between the two groups, and the predictive value of SII for the occurrence of AKI was analysed. RESULTS: The SII level (724.72 ± 235.50 vs. 522.38 ± 205.62, p < 0.001), the serum procalcitonin level (8.13 ± 15.52 vs. 4.52 ± 10.34 µg/L, p < 0.001), and the acute physiology and chronic health evaluation II score (14.26 ± 2.90 vs. 11.62 ± 2.26, p < 0.001) significantly increased in the AKI group compared with the control group, whereas the albumin level significantly decreased (30.60 ± 5.41 vs. 32.49 ± 5.31 g/L, p = 0.019). The receiver operating characteristic curve showed that SII was valuable in predicting AKI in patients with sepsis, with an area under the curve of 0.733 (95% confidence interval: 0.657-0.810, p < 0.001). The continuous renal replacement therapy intervention rate (88.52% vs. 0.00%, p < 0.001), the intervention rate of vasoactive drugs (34.43% vs. 3.75%, p < 0.001), and the hospital mortality rate (16.39% vs. 2.50%, p < 0.001) significantly increased in the AKI group compared with the control group. CONCLUSIONS: AKI was associated with poor prognosis in patients with sepsis. SII, procalcitonin and acute physiology and chronic health evaluation II (APACHE II) score were valuable in predicting the occurrence of AKI. SII may serve as a new marker in patients with sepsis.

Comparison between the modified Blalock-Taussig shunt and right ventricular outflow tract stent in the palliative treatment for tetralogy of Fallot. / 改良Blalock-Taussigåˆ†æµæœ¯ä¸Žå³å¿ƒå®¤æµå‡ºé“æ”¯æž¶æ¤å ¥æœ¯å§‘æ¯æ€§æ²»ç–—æ³•æ´›å››è”ç—‡çš„æ¯”è¾ƒ.

OBJECTIVES: For patients with tetralogy of Fallot (TOF) who are not suitable candidates for primary corrective surgery or have a high surgical risk, transcatheter right ventricular outflow tract (RVOT) stent implantation is considered a safe and effective palliative intervention. This study aims to investigate the therapeutic outcomes of RVOT stent implantation in neonates and infants with TOF in comparison with the modified Blalock-Taussig shunt (mBTS) and to compare the impact of the 2 palliative interventions on arterial oxygen saturation and pulmonary artery development in pediatric patients. METHODS: Clinical data of 32 patients with TOF admitted to the Second Xiangya Hospital of Central South University from March 2011 to March 2021 were retrospectively collected. The patients were divided into an mBTS group (undergoing mBTS, n=15) and a stent implantation group (undergoing RVOT stenting, n=17) according to the surgical procedures. The 2 groups were assessed and compared in the surgical-related arterial oxygen saturation, postoperative complication rate, mortality rate, and re-intervention rate. The development of the patients' main pulmonary artery, right pulmonary artery, and left pulmonary artery was assessed by z-scores according to echocardiographic results. RESULTS: The children in the stent implantation group were younger and less weighed compared with the mBTS group (both P<0.05). Compared with the preoperative period, children in the stent implantation group had significantly higher arterial oxygen saturation [(75±17)% vs (96±3)%, P=0.026]; z-scores of pulmonary trunk [(-2.82±1.27) points vs (0.86±0.77) points, P=0.014], right pulmonary artery [(-1.88±0.59) points vs (-0.28±0.71) points, P=0.011], and left pulmonary artery [(-2.34±0.36) points vs (-1.67±0.36) points, P=0.036] were significantly increased. However, there were no significant differences in arterial oxygen saturation and pulmonary artery z-scores between pre- and post-mBTS procedures (all P>0.05). CONCLUSIONS: RVOT stent would have good surgical outcomes used in TOF patients with low weight and severe comorbidities. It also leads to an higher postoperative oxygen saturation and better promotion of pulmonary artery growth with RVOT stent compared to mBTS.

Predictive Model for PICC Occlusion Risk for Patients in Intensive Care Units: A Retrospective Clinical Study.

Context: Peripherally inserted central catheters (PICCs) have a high incidence of catheter occlusion, but research exploring the risk factors for such an occlusion for patients in intensive care units (ICUs) is lacking. Objective: The study intended to examine the impact of multiple risk factors on the occurrence of PICC catheter occlusion to find evidence that can help clinical medical staff identify patients at an early stage who are at high risk of a catheter occlusion. Design: The research team performed a retrospective, observational clinical study. Setting: The study took place at a tertiary general hospital, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University in Wenzhou, China. Participants: Participants were 300 patients with a PICC who received treatment in the hospital's adult ICU between January 2019 and April 2022. Groups: According to the time of catheterization, the research team numbered the 1~300 participants and then selected one starting number to divided them into two groups according to the random number table. These two groups were: (1) a training group with 225 participants and (2) validation group with 75 participants. Outcome Measures: The main outcome measure was the evaluation of the factors impacting patients who had had a PICC occlusion during catheter retention, including complete and incomplete occlusions, to build a risk prediction model of PICC occlusion. A secondary outcome measure was the occurrence of extubation of the PICC discharge of the ICU patient. The research team performed a univariate analysis of the training group's data and a multivariate logistic regression analysis of the risk factors. The team: (1) built a risk prediction model of PICC occlusion using the independent risk factors for catheter occlusion for PICC patients in an ICU and (2) used the Hosmer-Lemeshow goodness-of-fit test to test the prediction model. A two tailed using p>0.05 indicated that the model had a good fit. Then, the team applied the model to the validation group and evaluated the model's predictive ability using a receiver operating characteristic (ROC) curve. The team considered an area under the curve (AUC) >0.5 to have predictive value. The larger the area was, the better the predicted value was. The incidence of PICC occlusion in the training group was 18.22%, including 10 participants with complete occlusion and 31 with partial occlusion. The team used the SPSS 22.0 and R software for statistical analysis. Results: The univariate analysis showed that 13 factors were associated with PICC occlusion, including: (1) an age ≥65 years (P < .001), a BMI of ≥24 kg/m2 (P < .001), (2) a BMI of ≥24kg/m2 (P = .002), (3) diabetes (P < .001), (4) stroke (P < .001), (5) hypertension (P < .001), (6) malignant tumors (P < .001), (7) a history of deep vein thrombosis (P < .001), (8) limb activity (P < .001), (10) flushing and sealing pipe frequency of Q8h (P = .035), (11) retention time (P < .001), (12) an increased platelet count (P = .036), (13) blood transfusions (P < .001), and (14) intravenous nutrition (P < .001). The independent risk factors for PICC occlusion included: (1) age ≥65 years-OR=1.224, P = .028; (2) BMI ≥24 kg/m2-OR=1.679, P = .004; (3) diabetes-OR=1.343, P = .017; (4) malignant tumors-OR=2.736, P < .001; (5) blood transfusions-OR=1.947, P < .001), and (6) intravenous nutrition-OR=2.021, P < .001. The frequency of flushing and sealing the pipe (Q8h)-OR=-2.145, P = .002-was a protective factor. In the training group, the area under the curve (AUC) for predicting a PICC occlusion was 0.917. The Hosmer-Lemeshow test of the prediction model showed that no significant differences existed in the test results within the model (χ2 = 5.830, P = .666), indicating that the model passed the internal validation. The ideal and calibration curves of the prediction model were highly coincident, and the model was well calibrated. The Hosmer-Lemeshow test of the validation group showed that no significant differences existed in the test results outside the model, suggesting that the model had high consistency. Conclusions: Age ≥65 years, BMI ≥24 kg/m2, diabetes, malignant tumors, blood transfusions, and intravenous nutrition were independent risk factors for PICC occlusion, while the frequency of flushing and sealing pipe (Q8h) was a protective factor. This prediction model had an outstanding ability to discriminate in identifying patients with a high-risk of PICC occlusion in the ICU.

Propionate alleviated post-infarction cardiac dysfunction by macrophage polarization in a rat model.

BACKGROUND: The propionate (C3), the important components of short-chain fatty acids (SCFAs), had the effect of inhibiting pro-inflammatory macrophages. Earlier macrophages phenotypic transition from pro-inflammatory M1 to reparative M2 in early stage was a central juncture of cardiac dysfunction mitigation after myocardial infarction (MI). METHODS: 160 Sprague-Dawley rats were assigned to 4 groups: sham group (n = 40), sham + C3 group (n = 40), MI group (n = 40) and MI + C3 group (n = 40). The rats in sham + C3 and MI + C3 group were treated with oral sodium propionate (200 mM), and equivalent concentration of sodium chloride was administered in sham and MI group as control. After 7 days of propionate adaptive feeding, rats were anesthetized and induced the MI by coronary occlusion. The classification of macrophages, the level of inflammatory factors and inflammatory signaling were estimated at 3rd days after thoracotomy, and the extent of myocardial fibrosis was evaluated at 7th and 28th days after operation. Echocardiography was estimated on 28th day after surgery. RAW264.7 cells, stimulated by LPS + IFN-γ with or without propionate, were harvested for western blot and supernatants were collected for cytokine analysis by ELISA. RESULTS: Propionate administration reduced the MI-induced myocardial fibrosis in infarcted border and attenuated cardiac function deterioration compared with MI group. In comparison with MI group, propionate promoted macrophages reduction, macrophage M2-like polarization, and inflammatory cytokines decrease in infarcted border zone following MI, which partly depends on the inhibition of JNK/P38/NFκB signaling pathways. CONCLUSIONS: Oral propionate in early stage, as a nutritional intervention, alleviated post-MI chronic cardiac remodeling and cardiac dysfunction at least in part by modulating macrophages polarization and pro-inflammatory cytokine, which were associated with reduction of JNK/P38/NFκB phosphorylation.